Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al

NPE Status
Practicing Entity
Declaratory Judgment
Yes
Civil Action
1:13-cv-00135
Filing Date
Venue
D.Del.
Termination Date
US Patent No
5569672
6025389

Patent Asserters:

Patent Asserter
GlaxoSmithKline LLC
8 Product company
Stiefel Laboratories, Inc.
8 Product company
Beecham Group, P.L.C.
8 Product company
Glaxosmithkline PLC
8 Product company
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
12 IP subsidiary of product company
Smithkline Beecham
8 Product company

Alleged Infringers:

Glenmark Pharmaceuticals Inc. (USA)
Glenmark Pharmaceuticals Ltd.
Glenmark Generics Inc. (USA)
Glenmark Generics Ltd.